Cynata Therapeutics Limited Stock
Stocks
CYP
AU000000CYP7
Biotechnology & Medical Research
OTC Markets Traded|
Market Closed -
Australian S.E.
03:59:10 30/10/26 pm AEDT
|
5-day change | 1st Jan Change | ||
| 0.0120 AUD | -.--% |
|
+9.09% | -96.52% |
| 22/10 | Cynata Therapeutics Limited Announces Resignation of Paul Wotton as Director, Effective November 25, 2026 | CI |
| 28/09 | Cynata Therapeutics Limited Auditor Raises 'Going Concern' Doubt | CI |
| Market Cap | 2.92M 2.06M 1.84M 1.69M 1.53M 2.87M 195M 20.19M 8.11M 103M 7.71M 7.55M 324M | P/E 2025 |
-3.27x | P/E 2026 | -0.36x |
|---|---|---|---|---|---|
| Enterprise Value | 2.02M 1.42M 1.28M 1.17M 1.06M 1.99M 135M 13.99M 5.62M 71.12M 5.34M 5.23M 224M | EV / Sales 2025 |
15.3x | EV / Sales 2026 | 1.47x |
| Free-Float |
54.57% | Yield 2025 * |
-
| Yield 2026 | - |
Australian S.E.AUD
| Markets | Quality | ||
|---|---|---|---|
Australian S.E.
| CYP | Delayed | |
OTC Markets
| CYYNF | Delayed | |
|
Deutsche Boerse AG
| 51S | Delayed | |
|
Börse Stuttgart
| 51S | Delayed |
Last Transcript: Cynata Therapeutics Limited
| 1 week | +9.09% | ||
| 1 month | +9.10% | ||
| 3 months | +0.01% | ||
| 6 months | -96.28% | ||
| Current year | -96.52% |
| 1 week | 0.01 |  | 0.01 |
| 1 month | 0.01 | | 0.02 |
| Current year | 0.01 | | 0.44 |
| 1 year | 0.01 | | 0.44 |
| 3 years | 0.01 | | 0.44 |
| 5 years | 0.01 | | 0.6 |
| 10 years | 0.01 | | 1.87 |
| Manager | Title | Age | Since |
|---|---|---|---|
Peter Webse
SEC | Corporate Secretary | 63 | 18/05/2012 |
| Director | Title | Age | Since |
|---|---|---|---|
Paul Wotton
CHM | Chairman | 65 | 28/02/2017 |
Kilian Kelly
BRD | Director/Board Member | - | 01/07/2023 |
Geoff Brooke
CHM | Chairman | 70 | 18/08/2020 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 1/6/23 | Buy | Chief Executive Officer | 55,813 | 0.0312% | ||
| 1/6/23 | Buy | Chairman | 139,534 | 0.0780% | ||
| 1/6/23 | Buy | Director | 139,534 | 0.0780% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -.--% | +9.09% | -95.38% | -91.11% | 2.06M | |
| -0.62% | -1.87% | +42.87% | +64.15% | 63.77B | |
| +0.35% | +3.20% | +14.40% | +81.76% | 56.37B | |
| +0.53% | +1.96% | +16.24% | +103.35% | 54.62B | |
| -2.81% | -4.31% | +23.50% | +47.83% | 44.06B | |
| -0.33% | -1.93% | +19.28% | +98.80% | 42.11B | |
| +0.55% | +2.31% | +225.14% | +866.21% | 41B | |
| +3.27% | +47.96% | +112.84% | +96.58% | 34.92B | |
| +1.22% | -1.44% | +14.57% | +46.95% | 32.82B | |
| +0.89% | +20.55% | -40.62% | +349.24% | 24.7B | |
| Average | +0.31% | +7.69% | +33.28% | +166.38% | 39.43B | |
| Weighted average by Cap. | +0.18% | +5.44% | +47.99% | +176.67% |
| 2025 | 2026 | |
|---|---|---|
| Net sales | 1.89M 1.33M 1.19M 1.09M 990K 1.85M 126M 13.03M 5.23M 66.24M 4.98M 4.87M 209M | 1.71M 1.2M 1.08M 992K 899K 1.68M 114M 11.83M 4.75M 60.14M 4.52M 4.42M 190M |
| Net income | -9.39M -6.61M -5.92M -5.44M -4.93M -9.22M -627M -64.9M -26.05M -330M -24.79M -24.27M -1.04B | -9.25M -6.51M -5.83M -5.36M -4.86M -9.08M -618M -63.92M -25.66M -325M -24.42M -23.9M -1.02B |
| Net Debt | -5.05M -3.55M -3.18M -2.93M -2.65M -4.96M -337M -34.9M -14.01M -177M -13.33M -13.05M -560M | -897K -631K -565K -520K -471K -881K -59.95M -6.2M -2.49M -31.53M -2.37M -2.32M -99.45M |
Employees
2
| Date | Price | Change | Volume |
|---|---|---|---|
| 30/10/26 | $0.0120 | -.--% | 111,168 |
| 29/10/26 | $0.0120 | -.--% | 83,000 |
| 28/10/26 | $0.0120 | +9.09% | 189,047 |
| 27/10/26 | $0.0110 | -.--% | 300,923 |
| 26/10/26 | $0.0110 | -.--% | 20,000 |
Annual profits - Rate of surprise
- Stock Market
- Stocks
- CYP Stock
Select your edition
All financial news and data tailored to specific country editions
